Orchestra BioMed Holdings (OBIO) Equity Ratio (2022 - 2025)
Orchestra BioMed Holdings (OBIO) has disclosed Equity Ratio for 4 consecutive years, with 0.42 as the latest value for Q3 2025.
- On a quarterly basis, Equity Ratio fell 31.99% to 0.42 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.42, a 31.99% decrease, with the full-year FY2024 number at 0.43, down 39.46% from a year prior.
- Equity Ratio was 0.42 for Q3 2025 at Orchestra BioMed Holdings, up from 0.01 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.89 in Q3 2022 to a low of 0.0 in Q1 2022.
- A 4-year average of 0.52 and a median of 0.61 in 2024 define the central range for Equity Ratio.
- Peak YoY movement for Equity Ratio: soared 151478.12% in 2023, then plummeted 98.87% in 2025.
- Orchestra BioMed Holdings' Equity Ratio stood at 0.55 in 2022, then skyrocketed by 30.01% to 0.71 in 2023, then crashed by 39.46% to 0.43 in 2024, then fell by 3.55% to 0.42 in 2025.
- Per Business Quant, the three most recent readings for OBIO's Equity Ratio are 0.42 (Q3 2025), 0.01 (Q2 2025), and 0.29 (Q1 2025).